Literature DB >> 8735608

Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells.

M B Crichton1, J E Nichols, Y Zhao, S E Bulun, E R Simpson.   

Abstract

The expression of transcripts of cytokines of the interleukin-6 (IL-6) family has been examined in human breast tumors, breast cancer cell lines, and adipose stromal cells, by means of reverse transcription polymerase chain reaction amplification. Of the six breast tumor samples examined, all expressed transcripts encoding IL-6 and Leukemia Inhibitory Factor (LIF). Four of the samples also expressed transcripts for oncostatin M (OSM) and IL-11, and three expressed the IL-6 receptor. Adipose stromal cells expressed IL-6, IL-11 and LIF, but not the IL-6 receptor, consistent with previous conclusions that IL-6 activity in these cells required addition of IL-6 soluble receptor. In the case of T47D cells, expression of IL-11 protein was confirmed by immunotitration. Moreover, in these cells, expression of IL-11 transcripts was induced 3-fold by addition of estradiol to the culture medium. These results add credence to our previous proposal that breast cancer development is regulated in part by local autocrine and paracrine mechanisms via epithelial/mesenchymal interactions, in which estrogen produced by stromal cells surrounding the tumor acts to stimulate the production of growth factors and cytokines by the tumor cells. Some of these may act to stimulate further the growth and development of the tumor, while these or other factors may act on the surrounding mesenchymal cells in a paracrine fashion to stimulate aromatase expression in the presence of glucocorticoids. Thus, a positive feedback loop is established which leads to the development and growth of the tumor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735608     DOI: 10.1016/0303-7207(96)03761-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  23 in total

1.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

2.  Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.

Authors:  Celeste Bolin; Ken Tawara; Caleb Sutherland; Jeff Redshaw; Patrick Aranda; Jim Moselhy; Robin Anderson; Cheryl L Jorcyk
Journal:  Genes Cancer       Date:  2012-02

Review 3.  Transcriptional regulation of the heat shock protein genes by STAT family transcription factors.

Authors:  A Stephanou; D S Latchman
Journal:  Gene Expr       Date:  1999

4.  Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.

Authors:  Jung Eun Shin; Su Hyung Park; Yeun Kyu Jang
Journal:  Mol Cells       Date:  2010-12-03       Impact factor: 5.034

5.  Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.

Authors:  Bin Su; Cynthie Wong; Yanyan Hong; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-26       Impact factor: 4.292

6.  Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

Authors:  Brian Bierie; Christine H Chung; Joel S Parker; Daniel G Stover; Nikki Cheng; Anna Chytil; Mary Aakre; Yu Shyr; Harold L Moses
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

Review 7.  HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.

Authors:  Rabia Nawaz; Sadia Zahid; Muhammad Idrees; Shazia Rafique; Muhammad Shahid; Ammara Ahad; Iram Amin; Iqra Almas; Samia Afzal
Journal:  Inflamm Res       Date:  2017-03-11       Impact factor: 4.575

8.  Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.

Authors:  Pavle Repovic; Etty N Benveniste
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

10.  Dissecting the dynamics of dysregulation of cellular processes in mouse mammary gland tumor.

Authors:  Wieslawa I Mentzen; Matteo Floris; Alberto de la Fuente
Journal:  BMC Genomics       Date:  2009-12-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.